| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_af579a48daf0e01300c218b9fef6ff37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_52fc3bab2ba64d449c3ec47ab8d8c1c7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a23c74b2b520cc76945f81fa87b375e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4b9ed9fbcb5e843849f1b3b2972e6e39 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04 |
| filingDate |
2010-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e3902e74a0fd691ca1a1c7b57afdb9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a048a74bcae65de4b2b4b6f5880a887
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba9a7729215c63465933307083e644f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2311aaea18e4ec511dc8a9ceb69e1c06 |
| publicationDate |
2011-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2011053507-A1 |
| titleOfInvention |
2-amino-9-[4-(4-methoxy-phenoxy) - piperid in -1-yl] -4-phenyl-indeno [1,2-d] pyrimidin -5 -one and its use as a highly selective adenosine a2a receptor antagonist |
| abstract |
This invention relates to a novel arylindenopyrimidine, A, and its therapeutic and prophylactic uses. Disorders treated and/or prevented include Parkinson's Disease. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013156614-A1 |
| priorityDate |
2009-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |